Jinxin Fertility Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JXFGF research report →
About the company
Jinxin Fertility Group Limited, established in 2003 and headquartered in Chengdu, China, functions as an investment holding company primarily focused on delivering assisted reproductive services (ARS) across both China and the United States. The company offers a comprehensive range of fertility treatments, encompassing artificial insemination, which can be performed using either a husband's or donor sperm, and advanced in vitro fertilization (IVF) techniques such as conventional IVF with embryo transfer or IVF enhanced by intracytoplasmic sperm injection (ICSI). Supporting these core services, Jinxin also provides patients with nutritional guidance, traditional Chinese medicine therapies, and psychological counseling.
- CEO
- Yang Dong
- IPO
- 2021
- Employees
- 3,198
- HQ
- Chengdu, CN
Price Chart
- Market Cap
- $741.66M
- P/E
- -3.71
- P/S
- 1.85
- P/B
- 0.40
- EV/EBITDA
- 17.02
- Div Yield
- 1.97%
- Gross Margin
- 32.57%
- Op Margin
- 3.89%
- Net Margin
- -37.21%
- ROE
- -10.66%
- ROIC
- 0.77%
- Revenue
- $2.58B · -8.21%
- Net Income
- $-950,955,721 · -435.91%
- EPS
- $-0.35 · -418.18%
- Op Income
- $197.94M
- FCF YoY
- -40.48%
- 52W High
- $0.50
- 52W Low
- $0.20
- 50D MA
- $0.29
- 200D MA
- $0.29
- Beta
- 0.78
- Avg Volume
- 869.304
Get TickerSpark's AI analysis on JXFGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our JXFGF coverage
Recent articles, reports, and earnings notes.
No research on JXFGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate JXFGF report →Similar companies
Peers in the same neighborhood.